A 5,000+ grant corpus, vectorized at multiple semantic scales, governed by an agentic knowledge graph, and applied to every draft we touch. Measured outcomes run 2–4× the national win rate.
Most “AI for grants” tools train on what they can scrape. We trained on what we won. A decade of high-performance grants, screened clients, summary-statement critiques, and reviewer scores, all interrogated at a depth no public corpus could support.
The credibility of a grant-AI system is upstream of any algorithm. It begins with the quality of the writing the system learns from. Most public datasets, including NIH RePORTER, SBIR.gov, and scraped abstracts, capture what was funded, not how it was written or why it scored. They expose titles, abstracts, award amounts, and outcome metadata. They do not expose the full Specific Aims, the Approach section, the figures, the budgets, or the language reviewers actually used in response. They are wide. They are also shallow.
Streamline’s data sources are selective by construction, and include a wide array of sources — we have called this our “corpus.” The corpus sources include a successful FOIA request submitted in 2023 (case #60904, fulfilled in early 2026) that comprises 5,910 SBIR/STTR grants and contracts, grants written by the principals of Streamline for their own startup companies, select client submissions, and grants provided to Streamline from companies that submitted proposals that Streamline did not write. From our internal data set, every grant in the training data was reviewed and selected by passing our Subject Matter Expert (SME) process prior to being included in the corpus. That screen explicitly filters for technical defensibility, commercial readiness, regulatory pathway clarity, and team execution capacity. The grants our clients shared with us before they began working with us are included only when they meet the same bar.
From a statistical-learning perspective, the depth of the per-grant record matters more than the size of the index. There are big limitations to other data sets. A model trained only on award-notice metadata learns what got funded, but it cannot learn how a Significance argument was framed, where an Approach section over-promised, or which clause of a Specific Aims page drew a strength comment. A model trained on full grant text paired with summary-statement language can. That depth, not raw volume, is what makes Streamline’s corpus a valuable knowledge base that informs causally driven factors that deliver wins and avoids losses.
Because this corpus includes client submissions, data governance and AI security are questions we take seriously from day one. Read our full approach to data security, confidentiality, and AI model governance →
Once you have a corpus that delivers on data sufficiency, the question becomes how deeply you can interrogate it. A grant is not a document. A single sentence can carry the entire weight of a Significance argument. A whole Approach section can fail because of one missing control measurement. The semantic structure that matters to a reviewer does not live at any one dimension, therefore we have vectorized at every probabilistic dimension that matters.
We embed the corpus with multiple models in parallel, each tuned to a different semantic register: PubMedBERT and S-PubMedBERT for biomedical density, SapBERT for entity-level disease and target alignment, SciBERT for general scientific phrasing, Nomic for long-context narrative coherence, and Google Gemini Embeddings 2 for multimodal capture that brings figures, charts, and study-design diagrams from the grant PDFs into the same retrieval surface as the prose. The same passage of grant text, and now the figure that sits beside it, becomes a stack of vectors, each capturing a different facet of why the application does or does not meet the threshold for sufficient performance. When a reviewer flags “thin preliminary efficacy evidence,” we actually retrieve precedent on the strength of biomedical entities, on the rhetorical structure of evidence claims, and on the visual quality of the supporting data figure. These different searches in different models converge into one unified layer that allows for context across the grant that represents the currently best known way to recapitulate an actual review.
Crucially, we organize or “chunk” at multiple scopes. Clause-level embeddings (over 324,000 of them) let us locate the exact sentences reviewers reward and penalize. Critique-paired embeddings attach each clause to the reviewer language it generated, including strength, weakness, criteria, and severity, so retrieval is grounded in scored precedent, thereby capturing the implication of the content to its outcome. Grant-level summaries capture the full proposal narrative that is leveraged for cross-application similarity, thereby driving longitudinal learning versus one-off conclusions. The result is a retrieval surface that can answer questions no flat embedding can: “For Phase 2 Cancer Drug grants, what clause structures consistently draw a strength comment in Significance and an offsetting weakness in Approach?”
The cluster geometry is insightful when visualized. Approach is the biggest contributor to the outcome. It is the criterion reviewers spend the most language on, and its semantic territory overlaps everything. Investigators separates cleanly to the side: the language reviewers use to describe team capability is structurally distinct from the language they use to describe science. Significance and Environment form thinner peripheral arms, with fewer comments but more concentrated topical signal; similarly for Innovation. When we retrieve precedent for a draft section, we are not just finding “similar text.” We are finding text that lives in the same neighborhood of the criterion’s contextual space, with the same valence (strength or weakness), at a similar severity tier.
Embeddings find similar text and similar contextual meaning. They do not find related facts. A grant about a cardiac monitoring device and a grant about a sepsis biomarker may sit far apart in any embedding space, yet share the same study section, the same reviewer-archetype tendencies, the same FDA pathway, the same commercialization milestone structure. Those relationships do not live in vectors. They live in a graph. Therefore, graphs represent structured, interconnected relationships (nodes and edges) for precise, multi-hop reasoning.
Streamline-Braintrust is our human and agentic knowledge graph layer. Each grant in the corpus is ingested as a node, and a population of LLM agents is responsible for discovering and maintaining its relationships to a heterogeneous graph of additional node types: granting institutes, study sections, reviewer archetypes, disease states, technology types, stages of development, regulatory pathways, commercialization routes, mechanism-of-action families, biomarker classes, and review-cycle patterns, among many other nodes. Our platform continuously re-evaluates edges as new grants are ingested and as new outcomes (scores, awards, resubmissions) become available and are reviewed by our human Streamline-Braintrust.
Force-directed view · simulating how grants and entities ingest, agents propose edges, and the graph re-settles
What makes the graph generative rather than deterministic is the agent layer. When a new grant enters the corpus, an ingestion agent extracts its features (institute, mechanism, disease, technology type, stage, etc.). A relational agent then proposes candidate edges to the existing graph: “This Phase 2 cardiac device grant routes through NIH NHLBI Study Section ZRG1 SBIB-T, where reviewer Archetype-7 has historically penalized soft endpoint definitions in implantable monitoring devices.” A verification agent checks the proposed edge against the historical critique evidence. A score-attribution agent connects the edge to the grant’s eventual summary statement. The graph does not stop growing. It increases in density, therefore improving its predictive power.
Over a decade, and thousands of grants, we have produced for the field something no other firm has: a structured, agent-curated map of which reviewer behaviors yield signal on which content patterns under which institute mechanisms. When a draft enters our system, we can query that map directly. We ask “what has this study section, this archetype, this mechanism, this indication, and this stage of development together produced as a critique pattern in the past?”
The corpus, the embeddings, and the graph exist to serve one purpose: when a grant is being written, Streamline-Braintrust AI knows, with evidence, what the highest-leverage decisions contribute to the desired outcome. We combine three sources of signal to produce that recommendation.
First, the historical grant corpus. Each passage in a new grant draft is matched against scored precedent at the same criterion, severity, and grant taxonomy. The taxonomy has named, classified, and arranged crucial features into ordered groups that comprise the structure of key dimensions for the platform. The strengths the system has seen reviewers reward in this segment are surfaced as suggested framings. Weakness patterns are flagged before submission, with the historical critique language attached so the writer can see exactly how a reviewer phrased the same concern in the past.
Second, peer-reviewed scientific literature and standard of care elucidation. A separate retrieval layer queries the published evidence base for the indication, mechanism, and study design under discussion. When a draft claims novelty, the system checks whether the claim is defensible against current literature. When a draft cites preliminary data, the system surfaces benchmarks from comparable published studies. We extend that same scrutiny to pending, active, and recently completed clinical trials, querying ClinicalTrials.gov and equivalent registries to detect competing programs, comparable enrollment timelines, and prior trial outcomes that a reviewer is likely to know about whether or not the draft cites them. We also run a deep standard-of-care analysis on the indication: current first-line, second-line, and salvage options, recent label expansions, guideline updates, and reimbursement landscape, so the application’s clinical positioning is grounded in what is actually being practiced today, not what was true when the science started. This is the layer that prevents over-claiming, exposes adjacent competition before a reviewer does, converts a Significance argument from rhetorical to evidentiary, and substantiates success thresholds for key metrics of performance in the Approach section.
Third, over 760 years of institutional grant-writing knowledge. The corpus tells us what reviewers have rewarded. The literature tells us what has been studied. Our human BrainTrust accumulated knowledge, including every resubmission lesson, every just-funded-vs-just-missed comparison, and every reviewer-archetype pattern catalogued by our writers and program managers, tells us how to act on those signals under real submission constraints. Streamline-Braintrust AI encodes that playbook as agent behaviors layered on top of the graph.
Every grant we ingest is screened, scored, and paired with reviewer language. Each ingest adds signal in the precise places thereby compounding the power of the signal. New clauses strengthen the embedding clusters around the criteria where they fall. New entities, institutes, study sections, and outcome traces add nodes and edges to Streamline-Brain. The agent population re-evaluates prior edges in light of the new evidence. The corpus does not get bigger so much as it gets denser, in the precise places where density matters: the evidence-against-criterion intersections where real applications succeed or fail.
That density is what generic LLM tooling cannot reach. A foundation model is trained on the open internet: abstracts, press releases, news, and public summaries. Generic AI tools have never seen a paired summary statement. Generic AI tools do not know which severity score a clause structure historically draws, which study section penalizes which framing, which institute mechanism rewards a specific commercialization narrative. It can write words that can be submitted. However, it cannot predict how reviewers will react to it, because it has no scored history to predict from. Streamline-Braintrust AI sits on top of that scored history, and every new ingest pushes the system’s accuracy in the segments that matter to our clients.
The practical consequence for an applicant is straightforward: a draft moving through Streamline today is being measured against a corpus and a graph that are denser than they were last quarter, with sharper retrieval in the segments where new grants have landed. The system is not static infrastructure. It is a working asset that gets smarter every four months.
Learn more about Streamline, that leads to a Subject Matter Expert review, by contacting us here. On a first call, we will discuss our differentiators, process, and tools we use to support your crucial innovation. As you progress in meeting our Product Funding Executives and Subject Matter Experts you will begin to learn and see how we are transforming how grants are effectively pursued and won.
The corpus is the foundation. The graph is the framework. The strategy is what delivers you a differentiated submission.